However, further functional experiments need to be performed to gain a deeper understanding of the underlying mechanisms and support the blockade of the CAV-1/NF-κB axis, which may provide broad prospects for the future clinical treatment of ALI. This evidence concerns the gene CAV1 and acute respiratory distress syndrome.